Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px
Organisation › Details

MS Ventures (Merck Serono Ventures)

MS Ventures is the strategic corporate venture capital fund of Merck Serono, the biopharmaceutical division of Merck. The fund was established in March 2009 and focuses primarily on early stage investments. MS Ventures has a strategic mandate and invests in companies that develop products and/ or technologies that could benefit patients in therapeutic areas relevant to Merck Serono. MS Ventures has a total of € 140 million under management for strategic investments, investments through its Israel BioIncubator and for spin-offs from the Merck Serono organization. *

 

Period Start 2009-03-23 established
Period End 2016-06-08 renamed
  Group Merck (DE) (Group)
  Today Merck Ventures B.V. (M Ventures, MV)
  Successor Merck Ventures B.V. (M Ventures, MV)
Products Industry venture capital
  Industry 2 BIOTECH
Person Person Bulthuis, Roel (Inkef Capital 201811– Managing Director + Head Heathcare before Merck M Ventures + Fortis Bank + Devgen)
     
Region Region Darmstadt
  Country Germany
  Street 250 Frankfurter Str.
  City 64293 Darmstadt
    Address record changed: 2013-05-26
     
Basic data Employees n. a.
     
    * Document for �About Section�: Merck Serono. (12/2/13). "Press Release: Merck Serono’s New Spin-off TocopheRx to Focus on Infertility Treatment. Merck Serono’s Entrepreneur Partnership Program (EPP) to Finance the 8th Spin-off". Darmstadt.
     
   
Record changed: 2019-04-15

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for Merck (DE) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BioPharm America 2019 Boston September 650x65px




» top